Get the Stockscreener App
60.41
2.80%
-1.756
Genedx Holdings Corp stock is traded at $60.41, with a volume of 336.52K.
It is down -2.80% in the last 24 hours and down -37.73% over the past month.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
See More
Previous Close:
$62.17
Open:
$62.22
24h Volume:
336.52K
Relative Volume:
0.47
Market Cap:
$1.71B
Revenue:
$267.23M
Net Income/Loss:
$-83.50M
P/E Ratio:
-19.43
EPS:
-3.11
Net Cash Flow:
$-59.99M
1W Performance:
-19.27%
1M Performance:
-37.73%
6M Performance:
+107.66%
1Y Performance:
+1,516%
1-Day Range:
$60.21
$64.25
1-Week Range:
$60.21
$76.13
52-Week Range:
$3.6773
$98.87
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings Corp
Sector
Industry
Phone
617 780 8742
Address
333 LUDLOW STREET, STAMFORD
Compare WGS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
60.41 | 1.71B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
567.56 | 219.06B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
207.73 | 151.02B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
144.78 | 42.12B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
459.49 | 37.71B | 3.84B | 866.24M | 792.60M | 10.37 |
|
IQV
Iqvia Holdings Inc
|
206.06 | 36.97B | 15.32B | 1.41B | 1.96B | 7.62 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-10-24 | Initiated | Craig Hallum | Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
Genedx Holdings Corp Stock (WGS) Latest News
GeneDX Holdings Stock Q4 2024 Earnings Preview (NASDAQ:WGS) - Seeking Alpha
GeneDx (NASDAQ:WGS) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Investors Buy High Volume of GeneDx Put Options (NASDAQ:WGS) - MarketBeat
GeneDx drops after short report; Wall Street analysts defend (update) - MSN
Sector Update: Health Care -February 05, 2025 at 03:29 pm EST - Marketscreener.com
GeneDx drops after short report; Wall Street analysts defend (update) (WGS:NASDAQ) - Seeking Alpha
Calamos Advisors LLC Reduces Holdings in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx Shares Fall After Short-Seller Grizzly Research Alleges 'Illegal Billing Practices' - Marketscreener.com
GeneDx targeted in short report by Grizzly Research By Investing.com - Investing.com South Africa
GeneDx targeted in short report by Grizzly Research - Investing.com Canada
Grizzly ResearchWe Are Short GeneDx -February 05, 2025 at 09:47 am EST - Marketscreener.com
Insiders Attest That GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud - Grizzly Reports
Gagnon Advisors LLC Has $14.42 Million Stock Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Insider Selling: GeneDx Holdings Corp. (NASDAQ:WGS) CFO Sells 275 Shares of Stock - MarketBeat
SG Americas Securities LLC Raises Holdings in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Baader Bank Aktiengesellschaft Sells 3,300 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Katherine Stueland Sells 1,657 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) Stock - MarketBeat
GeneDx Holdings Corp. (NASDAQ:WGS) Position Decreased by Gagnon Securities LLC - MarketBeat
GeneDx (NASDAQ:WGS) Shares Down 5.6%Here's What Happened - MarketBeat
GeneDx: Even After Up 2,700% in 2024, Upside Is Still in Play - MarketBeat
GeneDx Holdings Corp.'s (NASDAQ:WGS) large institutional owners must be happy as stock continues to impress, up 6.6% over the past week - Simply Wall St
WGSGeneDx Holdings Corp. Latest Stock News & Market Updates - StockTitan
GeneDx to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 18, 2025 - Business Wire
GeneDx Holdings Shares Surge Amid Mixed Signals - TipRanks
Nisa Investment Advisors LLC Acquires 50,009 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
309,500 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Bought by Zweig DiMenna Associates LLC - MarketBeat
GeneDx Holdings Corp. (NASDAQ:WGS) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
GeneDx Holdings Corp. (NASDAQ:WGS) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
GeneDx (NASDAQ:WGS) Shares Up 6%Here's What Happened - MarketBeat
GeneDx Holdings Corp. (NASDAQ:WGS) Shares Purchased by JPMorgan Chase & Co. - MarketBeat
Institutional owners may ignore GeneDx Holdings Corp.'s (NASDAQ:WGS) recent US$427m market cap decline as longer-term profits stay in the green - Yahoo Finance
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)January 17, 2025 - BioSpace
(WGS) Technical Data - Stock Traders Daily
Assenagon Asset Management S.A. Sells 61,642 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx (NASDAQ:WGS) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
GeneDx (NASDAQ:WGS) Trading Down 7.2%Here's What Happened - MarketBeat
Barclays PLC Acquires 14,681 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx Holdings: A Phenomenal Comeback With More Room To Run - Seeking Alpha
GeneDx raises Q4 adjusted gross margin view to 68% from 64% - Yahoo Finance
GeneDx Holdings (WGS) Surges 13.2%: Is This an Indication of Further Gains? - MSN
GeneDx anticipates higher-than-expected annual revenues - MSN
GeneDx Holdings Expects Strong 2024 Financial Performance - TipRanks
GeneDx forecasts strong revenue and gross margin growth By Investing.com - Investing.com South Africa
Why Have GeneDx Holdings Stocks Plummeted? - TipRanks
GeneDx forecasts strong revenue and gross margin growth - Investing.com India
GeneDx Announces Preliminary 2024 Financial Results - Business Wire
Insider Sell: Katherine Stueland Sells 51,420 Shares of GeneDx H - GuruFocus.com
Genedx Holdings Corp Stock (WGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Genedx Holdings Corp Stock (WGS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Jan 29 '25 |
Sale |
78.48 |
275 |
21,582 |
2,950 |
| Stueland Katherine | Chief Executive Officer |
Jan 29 '25 |
Option Exercise |
0.00 |
3,874 |
0 |
5,594 |
| Stueland Katherine | Chief Executive Officer |
Jan 29 '25 |
Sale |
78.48 |
1,657 |
130,046 |
3,937 |
8.74%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):